FDA amendment leverages the power of various Illumina sequencers for COVID-19 testing Today, the Food and Drug Administration (FDA) granted Illumina an amendment to the previous Emergency Use Authorization (EUA), expanding the installed base of next-generation sequencing (NGS) systems that can run COVIDSeq, a diagnostic test for COVID-19. With this amendment, more labs can embrace NGS’ […]
— World’s First Series Stored in DNA — SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (Nasdaq: TWST) today announced that for the first time, an episode of a Netflix Original Series has been stored in Twist’s synthetic DNA. DNA is an incredibly dense storage media (Graphic: Business Wire) “Many important documents, music and videos have […]
Praxis Genomics is first CLIA Lab to become a Bionano Certified Service Provider, will use Saphyr in its goal to help end diagnostic odyssey for patients. SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Praxis Genomics has been certified as a Bionano service provider, becoming the first clinical lab with CLIA certification […]
CARLSBAD, Calif. — In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System* designed to enable a future in which turnaround times for next-generation sequencing (NGS) […]
• QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing • QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research Hilden, Germany, and Germantown, Maryland – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with […]
Regarding the patent lawsuit initiated by Illumina against MGI in Hong Kong, the specific impact has yet to be determined. MGI believes that this patent litigation is an obvious attempt by Illumina to maintain a monopolistic market position and suppress the development of the industry. We intend to vigorously defend our intellectual property, and we have filed patent litigation against […]
The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical new vaccines and biologics SAN DIEGO — Today, Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput DNA printing, announced the introduction of their next-generation platform, the BioXp™ 3250 […]
TUCSON, Ariz., — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the commercial release and immediate availability of HTG EdgeSeq Reveal version 3.0, adding additional applications and software functionalities. The HTG EdgeSeq Reveal, launched in January 2019, is a web-based biostatistical analysis software suite […]
(ANN ARBOR, MICH.) Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to providing tools to […]
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib CARLSBAD, Calif. — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
